Delivery Order SPE2DB24D2205-SPE2DB26FDSWH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) with a contract ceiling value of $2,560.11. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.50 on September 3, 2025, for the supply of Eliquis 2.5 mg tablets (60-count package). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and is scheduled for completion by September 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on September 25, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $11,793.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is to be completed by July 31, 2025, with performance executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,323.56. This is a firm fixed price delivery order with an ultimate completion date of October 17, 2025, and represents a non-competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract value of $2,491.80. This is a firm fixed price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a firm fixed price ceiling value of $1,965.60. This is a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of September 26, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $2,060.28. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction under AmerisourceBergen's broader federal contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSWHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a ceiling value of $1,965.60. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of October 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, medical supplies, and healthcare commodities to support military healthcare programs worldwide. The current delivery order for Eliquis, a widely-used anticoagulant medication, exemplifies the company's role as a critical vendor within the federal medical supply chain serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/29/25 |